S$0.19 0.0 0.5%
Last Trade - 10:04am
| Market Cap | £31.9m |
| Enterprise Value | £19.0m |
| Revenue | £67.2m |
| Position in Universe | 4170th / 5956 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | TTM | 2020E | 2021E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|---|
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2020
|
31st Dec 2021
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Hyphens Pharma International Limited is a Singapore-based specialty pharmaceutical and consumer healthcare company. The Company comprises of three business entities: Hyphens Pharma Pte. Ltd., Pan-Malayan Pharmaceuticals Pte Ltd and Ocean Health Pte. Ltd. Its business segments include Specialty Pharma principals, Medical Hypermart and Digital, and Proprietary Brands. It is engaged in the business of selling and marketing specialty pharmaceutical products through Hyphens. Under Proprietary Brands division, it develops and sells a range of dermatological products and health supplement products. Its dermocosmetic products are marketed under its Ceradan and TDF brands, as well as health supplement products are marketed under its Ocean Health brand. The Company’s Medical Hypermart and Digital business involves supplying pharmaceutical products and medical supplies. It markets dermocosmetic products through medical professionals, including dermatologists, pediatricians and pharmacists.
| Last Annual | December 31st, 2019 |
| Last Interim | December 31st, 2019 |
| Incorporated | December 12, 2017 |
| Public Since | May 18, 2018 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Index | |
| Exchange | Singapore Exchange Securities Trading Ltd |
| Shares in Issue | 300,430,400 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 16 Tai Seng Street Level 4, 534138, Singapore |
| Web | |
| Phone | +65 6 2965751 |
| Auditors | RSM Chio Lim |
